{"transactions":[{"id":1176746,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81021,"kind":"person","name":"Lin Kenneth","position":1,"cik":"0001770623","reported_name":"Lin Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T01:41:33.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":4964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders."}],"balance_after":4964,"derivative":{"exercise_price":1.02,"expiration_date":"2035-04-03","underlying":"Common Stock","underlying_shares":4964},"source":{"system":"sec-edgar","filing":"0001641172-25-003091","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003091/ownership.xml","form_type":"4"}},{"id":1176745,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81021,"kind":"person","name":"Lin Kenneth","position":1,"cik":"0001770623","reported_name":"Lin Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-08T01:41:33.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders."}],"balance_after":25000,"derivative":{"exercise_price":1.02,"expiration_date":"2035-04-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001641172-25-003091","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225003091/ownership.xml","form_type":"4"}},{"id":1477431,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81021,"kind":"person","name":"Lin Kenneth","position":1,"cik":"0001770623","reported_name":"Lin Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T20:23:54.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":2482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest on the earlier of November 30,2024 or the date of the 2024 annual meeting of shareholders"}],"balance_after":2482,"derivative":{"exercise_price":2.1,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":2482},"source":{"system":"sec-edgar","filing":"0001493152-24-024125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224024125/ownership.xml","form_type":"4"}},{"id":1477430,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81021,"kind":"person","name":"Lin Kenneth","position":1,"cik":"0001770623","reported_name":"Lin Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-17T20:23:54.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options vest 50% on the date of the 2024 annual meeting of shareholders and 50% on the one year anniversary of the date of grant"}],"balance_after":41667,"derivative":{"exercise_price":2.1,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001493152-24-024125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224024125/ownership.xml","form_type":"4"}},{"id":2144935,"issuer":{"id":9617,"kind":"organization","name":"Anebulo Pharmaceuticals, Inc."},"owners":[{"id":81021,"kind":"person","name":"Lin Kenneth","position":1,"cik":"0001770623","reported_name":"Lin Kenneth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-04T20:11:04.000Z","date":"2022-04-21","kind":"grant","acquired":true,"shares":30425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option vests on March 1, 2023. Thereafter,  1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested."}],"balance_after":30425,"derivative":{"exercise_price":6,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":30425},"source":{"system":"sec-edgar","filing":"0001209191-22-052187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815974/000120919122052187/doc4.xml","form_type":"4"}}]}